A federal safety board just OK’d the first CRISPR trial to genetically alter humans

 In the spring of 2015, a group of Chinese scientists modified the DNA of 54 embryos using CRISPR/Cas 9 technology. Twenty-eight of those embryos were successful, but 26 – nearly half of them – failed, setting off a heated debate throughout the scientific community on the ethics of altering human genes. Regulators don’t currently allow the use of CRISPR on human DNA in the… Read More
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.